Jie Sheng
- Obstetrics and Gynecology top 2%
- Pregnancy and preeclampsia studies 6
- Uterine Myomas and Treatments 5
-
- Effects and risks of endocrine disrupting chemicals 9
- Reproductive Medicine top 5%
- Endometriosis Research and Treatment 5
- Cancer Research top 10%
- Immunology top 10%
-
- Birth, Development, and Health 7
-
- Ferroptosis and cancer prognosis 4
-
- Pancreatic and Hepatic Oncology Research 3
- Cancer Immunotherapy and Biomarkers 3
- Journals
- Journal of Clinical Investigation (1 paper)The Science of The Total Environment (1 paper)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jie Sheng
60 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 128
- Obstetrics and Gynecology 291
- Health, Toxicology and Mutagenesis 423
- Reproductive Medicine 194
- Cancer Research 260
- Immunology 244
Countries citing papers authored by Jie Sheng
This map shows the geographic impact of Jie Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Sheng more than expected).
Fields of papers citing papers by Jie Sheng
This network shows the impact of papers produced by Jie Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Sheng. The network helps show where Jie Sheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 34 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 23 | |
| 10 | 2020 | 5 | |
| 11 | 2018 | 9 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 305 | |
| 14 | 2018 | 23 | |
| 15 | 2018 | 17 | |
| 16 | 2018 | 21 | |
| 17 | 2017 | 81 | |
| 18 | 2017 | 41 | |
| 19 | 2017 | 23 | |
| 20 | 2011 | 26 |
About Jie Sheng
Jie Sheng is a scholar working on Obstetrics and Gynecology, Health, Toxicology and Mutagenesis and Reproductive Medicine, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (9 papers), Birth, Development, and Health (7 papers), Pregnancy and preeclampsia studies (6 papers), Endometriosis Research and Treatment (5 papers), Uterine Myomas and Treatments (5 papers), Ferroptosis and cancer prognosis (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Obstetrics and Gynecology (291 citations), Health, Toxicology and Mutagenesis (423 citations) and Reproductive Medicine (194 citations). Jie Sheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dan Lu, Kun Huang, Yanping Zhang, Jiahu Hao, Hui Gao, Yuanyuan Xu, Fangbiao Tao, Peng Zhu, Shuangqin Yan and Zhongxiu Jin. Their work appears in journals such as Journal of Clinical Investigation, The Science of The Total Environment and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.